DOSEF
Doseology Sciences Inc.·Healthcare
0.36
0.000%(+0.00)
Market ClosedLast Updated: — ET
52W L: $0.0552W H: $1.50
Doseology Sciences Inc.·Healthcare
KELOWNA, BC, March 30, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD |OTCQB: DOSEF | FSE: VU70 ) ("Doseology" or the "Company") a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it has arranged a non-brokered private placement of up to 3,225,806 units (each, a "Unit") at a price of $0.62 per Unit to raise aggregate gross proceeds of up to $2,000,000 (the "Offering"). Each Unit will consist of one common share in the capital of the Company (each, a "Share") and one Share purchase warrant (each, a "Warrant").
KELOWNA, BC, March 11, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a consumer product innovation company focused on oral stimulant pouch technologies, is pleased to announce that its common shares have commenced trading on the OTCQB® Venture Market in the United States under the symbol DOSEF. "We are pleased to expand trading access for U.S. investors through the OTCQB market," said Chris Jackson, Chief Executive Officer of Doseology Sciences Inc. "The United States represents both the largest capital market and one of the most important consumer markets for modern oral stimulant products, and this milestone supports our long‑term growth strategy.
KELOWNA, BC, March 4, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") today announced the launch of the Feed That Brain® Energy Pouches, marking the Company's first direct-to-consumer pilot program in the United States. Feed That Brain Energy Pouches deliver clean, controlled energy in a discreet oral pouch format, powered by Doseology®.
VANCOUVER, BC, Feb. 20, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") is pleased to announce the appointment of Larry Latowsky as a director and the Executive Chairman of its Board of Directors, effective February 18, 2026. Doseology is focused on developing precision-controlled oral delivery systems within the emerging oral stimulant category.
/PRNewswire/ -- Equity-Insider.com News Commentary - The global health and wellness sector is entering 2026 on a trajectory toward $6 trillion in annual
KELOWNA, BC, Jan. 21, 2026 /PRNewswire/ -- Doseology Sciences Inc. ( CSE: MOOD | PINK: DOSEF | FSE: VU70 ) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced the initiation of a pilot production run of non-nicotine, caffeine-based energy pouches under its wholly owned Feed That Brain® brand. Doseology's acquisition of Feed That Brain was a strategic decision rooted in alignment with a consumer demographic the Company views as increasingly influential in shaping the future of the oral stimulant category.
